Cerise Med Marketing Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-06-2024
- Paid Up Capital ₹ 0.10 M
as on 24-06-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 16.68%
(FY 2022)
- Profit -84.72%
(FY 2022)
- Ebitda -84.72%
(FY 2022)
- Net Worth -20.18%
(FY 2022)
- Total Assets -0.70%
(FY 2022)
About Cerise Med Marketing
The Company is engaged in the Recycling & Waste Management Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Harish Laddha, Mangesh Surve, and Arpit Bohra serve as directors at the Company.
- CIN/LLPIN
U51433MH2020PTC340552
- Company No.
340552
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jun 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cerise Med Marketing?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arpit Bohra  | Director | Current | |
| Harish Laddha | Director | 12-Jun-2020 | Current |
| Mangesh Surve | Additional Director | 18-Jun-2022 | Current |
Financial Performance and Corporate Structure Insights of Cerise Med Marketing.
Cerise Med Marketing Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.68% increase. The company also saw a substantial fall in profitability, with a 84.72% decrease in profit. The company's net worth observed a substantial decline by a decrease of 20.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cerise Med Marketing?
Unlock access to Cerise Med Marketing's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Hash Value Advisors Private LimitedActive 5 years 10 monthsHarish Laddha and Arpit Bohra are mutual person
- Bl Inves And Ventures Limited Liability PartnershipActive 4 years 9 months
Harish Laddha and Arpit Bohra are mutual person
- Microhard Impex Private LimitedActive 4 years 5 months
Harish Laddha and Arpit Bohra are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cerise Med Marketing?
Cerise Med Marketing has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cerise Med Marketing, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cerise Med Marketing's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
